Business Context and Reporting Period
Alumis Inc. (ALMS), an emerging growth company incorporated in Delaware, filed this Form 8-K on June 27, 2024. The report details a material definitive agreement entered into on the same date regarding a private placement of equity securities.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data point disclosed is the capital raise:
- Transaction Value: $40.0 million
- Shares Issued: 2,500,000 shares of voting common stock
- Price Per Share: $16.00
- Expected Closing Date: On or before July 22, 2024
Material Changes
The material change reported is the entry into a Common Stock Purchase Agreement with AyurMaya Capital Management Fund, LP. This transaction represents a significant increase in the company's equity capital pending the closing of the private placement.
Outlook, Risks, and Unusual Items
Management Commentary: The agreement includes customary representations, warranties, and termination provisions. The transaction is being conducted in reliance on exemptions from registration requirements under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D.
Risks and Contingencies: The filing notes that the representations and warranties were made solely for the benefit of the parties to the agreement and may be subject to limitations. The transaction is contingent upon the closing occurring on or before July 22, 2024.
Investor Verification Checklist
- Confirm the final closing date of the private placement (expected by July 22, 2024).
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) for specific covenants and termination rights.
- Verify the impact of the 2,500,000 new shares on existing shareholder dilution.
- Monitor subsequent filings for the actual receipt of the $40.0 million proceeds.